Sort
15,273 grants matching “antimicrobial resistance”
Evaluating darobactins as antimicrobial agents
$595,176Kim Lewis · Northeastern University · R01 · FY2024 · AI
Evaluating darobactins as antimicrobial agents
$595,176Kim Lewis · Northeastern University · R01 · FY2022 · AI
Evaluating darobactins as antimicrobial agents
$595,176Kim Lewis · Northeastern University · R01 · FY2025 · AI
The matrix of Pseudomonas aeruginosa biofilms
$595,147Daniel J Wozniak · Ohio State University · R56 · FY2010 · AI
Quorum sensing, diversity and skin inflammation
$594,998Alexander R Horswill · University Of Colorado Denver · R01 · FY2023 · AI
RFA-CK20-004: Infection Prevention and Antimicrobial Stewardship: Minding the Gaps: The Iowa Prevention Epicenter
$594,979Loreen A Herwaldt · University Of Iowa · U54 · FY2025 · CK
Aerosol delivery of combinational therapeutics targeting deadly lung infections
$594,930Qi Zhou · Purdue University · R01 · FY2025 · HL
Development of antibacterial agents and materials
$594,839Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
SEI: Data Mining for Multiple Antibiotic Resistance
$594,836Christopher M Jermaine · University Of Florida · · FY2006 · CSE
BIOCHEMICAL BASIS OF DELAYED TYPE HYPERSENSITIVITY
$594,756Harvard University (Sch Of Public Hlth) · R01 · FY2002 · AI
Mucosal Immune Defense Mechanisms of the Urinary Bladder
$594,739Marco Colonna · Washington University · R01 · FY2024 · DK
Impact of chlorhexidine bathing on reducing infections in children with cancer
$594,723Danielle M Zerr · Seattle Children'S Hospital · R01 · FY2012 · CA
Spread of Community-Acquired MRSA Among Household Contacts
$594,616Robert S. Daum · University Of Chicago · R01 · FY2009 · AI
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$594,607Joshua William Schaeffer · Colorado State University · R01 · FY2021 · OH
Antimicrobial Resistant Bacteria: Exposures and Health of Cattle Workers
$594,220Joshua William Schaeffer · Colorado State University · R01 · FY2022 · OH
Durability of systemic and lung immune correlates of BCG-induced protection against M. tuberculosis infection
$594,124Elisa Nemes · University Of Cape Town · R01 · FY2022 · AI
Phage-Polymer Nanoparticles for Treatment of Antibiotic-Recalcitrant Wound Biofilm Infections
$593,860Vincent M. Rotello · University Of Massachusetts Amherst · R01 · FY2025 · AI
Durability of systemic and lung immune correlates of BCG-induced protection against M. tuberculosis infection
$593,748Elisa Nemes · University Of Cape Town · R01 · FY2024 · AI
Quorum sensing, diversity and skin inflammation
$593,716Alexander R Horswill · University Of Colorado Denver · R01 · FY2024 · AI
Toward novel therapies against Lyme disease through the inhibition of lysinoalaine cross-linking in the bacterial flagella.
$593,469Brian R Crane · Cornell University · R01 · FY2023 · AI
Toward novel therapies against Lyme disease through the inhibition of lysinoalaine cross-linking in the bacterial flagella.
$593,469Brian R Crane · Cornell University · R01 · FY2022 · AI
Advancement of poxvirus inhibitor
$593,447John H Connor · Boston University Medical Campus · R01 · FY2022 · AI
Designing new aminoglycosides to alleviate inner ear toxicity
$592,955Anthony J Ricci · Stanford University · R01 · FY2018 · DC
Designing new aminoglycosides to alleviate inner ear toxicity
$592,955Anthony J Ricci · Stanford University · R01 · FY2017 · DC
Designing new aminoglycosides to alleviate inner ear toxicity
$592,955Anthony J Ricci · Stanford University · R01 · FY2019 · DC